Lexicon Pharmaceuticals (LXRX) Other Non Operating Income (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Other Non Operating Income data on file, last reported at $1.5 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 30.46% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $6.2 million, a 50.66% decrease from a year earlier, with the FY2025 full-year figure at $6.9 million, down 43.8% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $1.5 million, up from $1.3 million in the prior quarter.
• Over the last five years, Other Non Operating Income for LXRX reached as high as $4.1 million in Q2 2024 and fell as low as $14000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $1.8 million across 5 years, with a median of $1.6 million in 2025.
• Across the five-year window, Other Non Operating Income tumbled 70.83% in 2022 and surged 7250.0% in 2023, its largest moves.
• Year by year, Other Non Operating Income stood at $887000.0 in 2022, then surged by 170.8% to $2.4 million in 2023, then rose by 17.78% to $2.8 million in 2024, then slumped by 54.72% to $1.3 million in 2025, then increased by 20.45% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $1.5 million in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q3 2025.